BioPharmSignal logoBioPharmSignal

Company Sector

Stem Cell Therapy for Cardiac Disease

Stem Cell Therapy for Cardiac Disease is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Stem Cell Therapy for Cardiac Disease, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Why watch Stem Cell Therapy for Cardiac Disease

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Stem Cell Therapy for Cardiac Disease news

The latest feed items from companies currently grouped under Stem Cell Therapy for Cardiac Disease.

  1. 01

    BEATHeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

    Source: HeartBeam

  2. 02

    BEATHeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

    Source: HeartBeam

  3. 03

    BEATHeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

    Source: HeartBeam

  4. 04

    BEATHeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

    Source: HeartBeam

  5. 05

    BEATHeartBeam Reports First Quarter 2026 Results

    Source: HeartBeam

  6. 06

    BEATHeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

    Source: HeartBeam

  7. 07

    BEATHeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

    Source: HeartBeam

  8. 08

    BEATHeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

    Source: HeartBeam

  9. 09

    BEATHeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

    Source: HeartBeam

  10. 10

    BEATHeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

    Source: HeartBeam

  11. 11

    BEATHeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

    Source: HeartBeam

  12. 12

    BEATHeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

    Source: HeartBeam

  13. 13

    BEATHeartBeam Reports Fourth Quarter and Full Year 2025 Results

    Source: HeartBeam

  14. 14

    BEATHeartBeam Announces Proposed Public Offering of Common Stock

    Source: HeartBeam

  15. 15

    BEATHeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

    Source: HeartBeam

  16. 16

    BEATHeartBeam Announces Closing of $10 Million Public Offering of Common Stock

    Source: HeartBeam

  17. 17

    BEATHeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

    Source: HeartBeam

View all latest news

Companies in Stem Cell Therapy for Cardiac Disease

2 companies tagged with Stem Cell Therapy for Cardiac Disease.

BEAT

HeartBeam

HSCS

HeartSciences

Frequently Asked Questions

What does the Stem Cell Therapy for Cardiac Disease sector include?

Stem Cell Therapy for Cardiac Disease is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Stem Cell Therapy for Cardiac Disease, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

How many companies are currently tagged with Stem Cell Therapy for Cardiac Disease?

2 companies are currently grouped under Stem Cell Therapy for Cardiac Disease on BioPharmSignal.

Which companies are most visible in the Stem Cell Therapy for Cardiac Disease group right now?

BEAT, HSCS are among the companies currently shown on this sector page.

How can I watch news for Stem Cell Therapy for Cardiac Disease?

Use the Watch button on this page to subscribe to Stem Cell Therapy for Cardiac Disease headlines and related company updates through your BioPharmSignal saved filters.

What kinds of updates usually appear for Stem Cell Therapy for Cardiac Disease?

The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Stem Cell Therapy for Cardiac Disease.